Intellia Therapeutics NTLA has outperformed the market over the past 5 years by 32.37% on an annualized basis.
Buying $1,000 In NTLA: 5 years ago, an investor could have purchased 76.22 shares of Intellia Therapeutics at the time with $1,000. This investment in NTLA would have produced an average annual return of 48.02%. Currently, Intellia Therapeutics has a market capitalization of $6.94 billion.
Intellia Therapeutics's Share Price Over Last 5 Years
If you had invested $1,000 in Intellia Therapeutics you would have approximately $7,106.71 today.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
You can check out Benzinga's market data in an enhanced view on Benzinga Pro
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.